Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07440238
PHASE2

Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults

Sponsor: Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

Septic arthritis is a severe infection associated with significant morbidity and mortality. Despite eradication of the microorganisms, persistent inflammation may lead to substantial long-term functional joint sequelae. The use of corticosteroids could reduce this inflammation, thereby improving functional joint outcomes and facilitating first-line medical treatment. The hypothesis of this study is that corticosteroid administration, in addition to antibiotic therapy, reduces persistent inflammation and improves functional joint prognosis in adult patients with acute septic arthritis.

Official title: Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults: Randomized Double-blind Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2026-03-30

Completion Date

2026-09

Last Updated

2026-02-27

Healthy Volunteers

No

Interventions

DRUG

oral prednisone or placebo at a dose of 60 mg per day for 7 days

oral prednisone or placebo at a dose of 60 mg per day for 7 days

Locations (1)

Hopital Robert Ballanger

Aulnay-sous-Bois, France